History & Mission
FODs Defined
Newborn Screening
Medical Information
Support Resources
Coping & Healing
Family Stories

Love Messages

Newsletters
Book Reviews
Sites of Interest
Join Our Email List
Nutrition & Recipes
If My Child is Sick
Pharmaceuticals
Educational Info
Insurance Info
In the News
Online Forms
FAQs
Disclaimer

©1991-2008
Deb Lee Gould & FODSupport.org

Sample Letter for Advocating FOD Newborn Screening
Source: Deb Gould, Director, FOD Family Support Group

January 1, 2000

Dear (Insert Legislature/Health Committee person's name):

I am the Director of a National Family Support Group for families coping with rare genetic Fatty Oxidation Disorders (FOD). With many of these diseases, children cannot break down fats for energy because an important enzyme is either missing or not working correctly. Death can occur when the disease goes undiagnosed and untreated. Many of these disorders are often misdiagnosed as Sudden Infant Death or Reye Syndrome.

My letter to you is prompted by a very personal experience--the sudden death of my 21-month-old daughter, Kristen, on July 21, 1985, from an undetected metabolic deficiency called MCAD, one of the many Fatty Oxidation Disorders. Our second child was diagnosed at birth after we read about MCAD during his pregnancy and our third child is a carrier. To say the least, my family has been forever changed by this disease. It took doctors one year after her death to correctly diagnose our daughter's disorder after intially misdiagnosing her with Reye Syndrome—a diagnosis we just did not accept! It was a year spent in hell from not knowing why she died.

I strongly believe that if all Fatty Oxidation Disorders were tested as part of the ROUTINE NEWBORN SCREENING for infants in our country, our daughter would still be alive today. Yet, because her disorder was not diagnosed AT BIRTH, Kristen went from a thriving, energetic, and beautiful little girl to a STARK DEATH STATISTIC! And our family is not alone.

My letter is to alert you that CHILDREN ARE SUFFERING AND DYING NEEDLESSLY—WITH YOUR HELP, THAT CAN CHANGE!

I am asking you to consider bringing this issue to your Health and Medical committees and policymakers in order to change the law and PROMOTE THE INCLUSION OF FATTY OXIDATION DISORDERS IN THE ROUTINE NEWBORN SCREENING TESTING.

Metabolic disorders are the second most difficult medical problem to diagnose, according to a recent Gallup organization survey of pediatricians. Undiagnosed disorders have been linked to complications such as cardiomyopathy, developmental disabilities, seizures, and for some, death. Only 52% of the pediatricians were familiar with various metabolic disorders, and of those, only 43% knew that blood tests were necessary to confirm a diagnosis. Using the PKU blood spot, infants can now be tested for 38 different metabolic disorders for $3-$20 per test. Don't you think that SAVING THE LIFE OF A CHILD IS WORTH THIS SMALL FEE?

Fatty Oxidation Disorders meet the 3 Criteria that have been established for metabolic diseases to be tested at birth. 1) High Enough Frequency: Conditions already tested in many states, such as Cystic Fibrosis, PKU, and Galactosemia, occur in frequencies of 1 in 2000, 1 in 15,000 and 1 in 50,000 respectively, and may vary yearly and from state to state. Some of the FODs, such as MCAD, occur 1 in 10-20,000. 2) Established Newborn Test: Many of the FODs can now be diagnosed using Tandem Mass Spectrometry on a blood spot. The child's PKU card is often used as the sample. Researchers have also developed prenatal diagnosis methods using amniocytes. However, the Mass Spectrometry offers a diagnosis in a shorter period of time. Because the cost of the necessary equipment may be expensive for EACH state to acquire, our group is suggesting possibly more cost effective Regional Testing Centers instead of individual state centers. 3) Established Treatment: Many of the FODs are successfully treated with FDA approved medications, as well as diet restrictions and/or supplementations.

As a spokesperson for the FOD Family Support Group, I strongly urge you to be proactive on this issue and consider advocating the inclusion of these disorders for Newborn Screening, as well as appropriating future funding necessary for the cost of equipment and testing. I would be very glad to discuss this vital issue with you at your convenience.

Treatment cannot begin WITHOUT AN ACCURATE DIAGNOSIS! EARLY DIAGNOSIS THROUGH ROUTINE NEWBORN SCREENING OF FATTY OXIDATION DISORDERS would most definitely PREVENT NEEDLESS DEATHS AND IMPROVE THE LIVES OF OUR CHILDREN AND THEIR FAMILIES.

Respectfully,

Deb Lee Gould, MEd
Director, FOD Family Support Group
MCAD Parent and Grief Consultant
805 Montrose Drive
Greensboro, NC 27410
336-547-8682

 


Home
Contact Us
Share This Site
Translate This Site